NanoDrug Open Access Journals
Thanks to the production and manufacturing of nanostructures,
nanodrug delivery is designed to overcome these challenges. Nanostructures have been reported to have the power to protect
drugs from degradation inside the food channel; the technology also enables the delivery of medication to a number of body areas.
Nanodrug open access journal focussing on the application of
nanotechnology throughout the biomedical field in diagnostic, therapeutic, and
drug delivery systems. Reflecting the increasing activity of this emerging specialty, this journal aims to highlight research and development that lead to potential clinical applications in the prevention and treatment of diseases.
High Impact List of Articles
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
Relevant Topics in Clinical